Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 11;14:2335–2353. doi: 10.2147/DDDT.S249093

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Hassan et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Effect of GLM on fibrosis in CP-induced liver injury. (1) Representative microscopic pictures of Masson trichrome stained liver sections, showing moderate blue-stained collagen deposition around central vein (CV) and in portal areas (PA) scored 2 (A–C) (black arrows) in i.p group. Mild blue-stained collagen deposition around CV and in PA scored 1 (D–F) (black arrows) in EOD group, no collagen deposition around CV and in PA score 0 (G–I) in daily group. X: 100 bar 100 (A, D, and G) and X: 400 bar 50 (B, C, E, F, H, and I). (2) Statistical analysis of collagen deposition scores in all examined sections of CP-induced liver injury. Collagen deposition scores showing a significant reduction in fibrosis scores in all groups treated with GLM when compared with CP group. Different small alphabetical letters means significant when P< 0.05. ^aSignificant against control group; ^bsignificant against GL group; ^csignificant against CP group; ^dsignificant against i.p group.